Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
Add more filters










Database
Language
Publication year range
2.
Akush Ginekol (Mosk) ; (7): 31-5, 1990 Jul.
Article in Russian | MEDLINE | ID: mdl-2240446

ABSTRACT

Pregnancy in patients with a history of thrombotic complications puts them at a great risk of thrombosis and obstetric complications (hypoxia, intrauterine hypotrophy, bleedings). Functional strain of the hemostasis system occurs at the onset of pregnancy in women with a history of thrombotic complications without clinical symptoms of thrombosis. The incidence of disseminated intravascular coagulation with activation of both pro-coagulation and platelet-mediated hemostasis is 33% and that with activation of only platelet-mediated hemostasis is 64%. Differential use of antithrombotic drugs prevents thrombosis recurrence in 98% of patients.


Subject(s)
Disseminated Intravascular Coagulation/prevention & control , Fibrinolytic Agents/administration & dosage , Hemostasis/physiology , Pregnancy Complications, Cardiovascular/prevention & control , Pregnancy Complications, Hematologic/prevention & control , Thromboembolism/prevention & control , Adult , Disseminated Intravascular Coagulation/blood , Disseminated Intravascular Coagulation/etiology , Female , Hemostasis/drug effects , Humans , Pregnancy , Pregnancy Complications, Cardiovascular/blood , Pregnancy Complications, Cardiovascular/etiology , Pregnancy Complications, Hematologic/blood , Pregnancy Complications, Hematologic/etiology , Recurrence , Thromboembolism/blood , Thromboembolism/etiology
3.
Akush Ginekol (Mosk) ; (8): 30-3, 1989 Aug.
Article in Russian | MEDLINE | ID: mdl-2817276

ABSTRACT

In the presence of low-dosage administrations of heparin the system of hemostasis was studied in 50 pregnant females with placental failure and the chronic DIC syndrome. The efficacy of the treatment conducted was assessed with regard to the revealed levels of coagulation natural inhibitors, the products of fibrinogen-fibrin degradation, the degree of thrombocytic functional recovery and stabilization of the chronometric values of coagulation. The latter parameters considered together with the levels of heparinemia served as the criteria for the safety of the drug dosages employed.


Subject(s)
Blood Coagulation , Disseminated Intravascular Coagulation/drug therapy , Heparin/therapeutic use , Placenta Diseases/blood , Placental Insufficiency/blood , Pregnancy Complications, Hematologic/drug therapy , Adult , Blood Coagulation/drug effects , Disseminated Intravascular Coagulation/etiology , Female , Humans , Placental Insufficiency/complications , Pregnancy , Pregnancy Complications, Hematologic/etiology
SELECTION OF CITATIONS
SEARCH DETAIL
...